/PRNewswire/ The global cell lysis & disruption market size is expected to reach USD 7.95 billion by 2028 according to a new study conducted by Polaris.
/PRNewswire/ The global cell lysis & disruption market size is expected to reach USD 7.95 billion by 2028 according to a new study conducted by Polaris.
kits and reagents segment dominated the market with its largest revenue share contribution, owing to
the increasing use of consumables for mycoplasma analysis while conducting cell culture research work and related activities.
In terms of technology, the
Polymerase Chain Reaction (PCR) segment held the majority of the market share and is expected to constitute more than half of the market over the forecast period.
High specificity, efficiency, and preciseness are some of the key attributes that make PCR ideal for mycoplasma analysis.
Pharmaceutical & biotechnology companies market segment accounted for over 25% of the
revenue share in 2019 owing to the growing demand for mycoplasma testing for cell culture research and several research & development activities